Cobro Ventures is a private investment firm focused on tech and biotech.

Our team has a 25+ year track record as founders, operators, and investors in technology businesses with multiple successful exits via IPO and M&A. Launched by the entrepreneurs behind OPNET Technologies, Inc., we believe in "doing well by doing good" — a favorite phrase from our late co-founder Marc A. Cohen. We provide resources, expertise, and capital to create significant value during critical phases of innovation.

Select Cobro Ventures Projects

Avatar Seed → Nasdaq IPO → Acquired

Tech

Network and Application Performance Management
Avatar Seed → Acquired

Biotech

Selective HDAC Inhibition for Treating Critical Diseases
Avatar Seed → Nasdaq IPO

Biotech

Targeted Protein Degradation
Avatar Seed → Nasdaq IPO

Biotech

Activating the Body’s Innate Healing Ability
Avatar

Tech

Private Online Spaces™
Avatar

Tech

AI and Image-Guided Therapy
Avatar

Biotech

Synthetic Miniprotein Therapeutics
Avatar

Biotech

RNA-Directed Therapeutics

Across all our projects we seek to have a big impact, bet on world class scientific and technology experts, and leverage our experience with intellectual property and strategic business development.

Contact

Please direct general inquiries to info@cobroventures.com.

175 Chain Bridge Rd.
McLean, VA 22101